Benoit Destenaves
4Patents
0h-index
19Co-inventors
31Inventor score
Filing activity: Jun 20, 2003 → May 10, 2012
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9555110B2 | Anti-alpha-V integrin antibody for the treatment of prostate cancer | Chemistry; Metallurgy | 0 | Active |
| US9175347B2 | Genomic markers for prediction of long-term response to growth hormone (GH) therapy | Physics | 0 | Active |
| US7442519B2 | KCNQ2-15 potassium channel | Physics | 0 | Expired |
| US9206480B2 | Genomic markers for prediction of long-term response to 2 years of growth hormone (GH) therapy | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.